MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,773.95
+0.66%
NASDAQ 100
$31,076.44
+0.87%
DOW JONES
$51,268.00
+0.18%
NASDAQ Composite
$27,477.31
+1.05%
RUSSELL 2000
$2,833.80
+0.66%
CBOE VIX
$15.52
+1.37%
Sector Heatmap
Technology+0.56%
Financials+0.73%
Healthcare+0.72%
Consumer Cycl+0.35%
Consumer Staples+0.63%
Energy+0.99%
Industrials+0.09%
Materials+1.31%
Real Estate-0.34%
Utilities+0.35%
Comm Services+1.17%
KPTI — Karyopharm Therapeutics Inc.
NasdaqKaryopharm Therapeutics Inc.
$0.67
-0.13(-16.42%)
- O
- 0.80
- H
- 0.80
- L
- 0.63
- V
- 1.97M
⏱️ End-of-day dataAs of Oct 5, 2026
Chart
About KPTI
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateNov 6, 2013
Employees228
Stock ExchangeNasdaq
Ticker SymbolKPTI
Websitehttps://www.karyopharm.com
Key Financial Statistics
| Market Cap | $18.20M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.63 - $10.99 |
| 52-Week Avg Volume | 835.0K |
| VWAP | $0.69 |
| Transactions | 6,718 |
| Total Recorded Bars | 3,246 days |